Good morning.

Will a vaccine end the pandemic? At Fortune Brainstorm Health this week, there was lots of talk about the 200-plus efforts to find a COVID vaccine, and the extraordinary collaboration among companies and governments to get vaccines tested, manufactured and distributed—far faster than ever before. “We are taking what normally takes five to seven years, and doing it in five to seven months,” said Johnson & Johnson CEO Alex Gorsky.

But Gorsky—whose company is one of the leaders in the vaccine race—also issued a strong warning to the group not to think of a vaccine as a silver bullet.

Gorsky said he still hopes to have “hundreds of millions” of doses of a vaccine on the market by the first quarter, and more than a billion by the end of next year. But, he said, “none of us should be thinking that this is the single solution that is going to take us back to the old normal.” There are issues about how effective the vaccine will be, how many doses it will require, and how long its protection will last.

“A vaccine, while a very critical element to bringing an end to this pandemic, is part of

The net worth of a typical Black family is only 10% of that of the typical white family, and the unemployment rate for Black Americans consistently has been double that of white Americans for four decades. These are just two of the outcomes resulting from long-standing systemic disadvantages that perpetuate an inequality of opportunity based on the color of one’s skin. 

This past month’s national dialogue on racial equality has brought many painful truths to the fore. Acknowledging these truths is important. Taking action to address them is essential. 

The U.S. Chamber of Commerce is the largest lobbying organization in the nation, representing businesses of all sizes across all sectors, touching every corner of our country. With that reach comes a responsibility to drive sustained action to eliminate systemic disadvantages. Convinced that our own previous efforts have been insufficient, we have committed to put the collective muscle of American business behind an urgent nationwide push for equality of opportunity.  

Two weeks ago, we convened more than 500 state and local chambers of commerce and business associations from across the country; business, government, academic, and civic leaders; and thousands of others for a National Summit on Equality of Opportunity. Informed by this dialogue, …


10 min read

Opinions expressed by Entrepreneur contributors are their own.


During a , it becomes especially important for early-stage businesses to prove why they matter more than other companies. In this climate, purpose-driven businesses are the only ones who can say for certain that the world is a better place with them in it. 

When your has an important mission at its heart, you will have more power to attract talent, valued mentors, investors and customers. That’s because today’s consumers are drawn to ethical products from ethical brands. Employees are willing to work for less pay if their company shares their values, and these trends are only going to become more ingrained as the world comes to terms with recent events.

Research shows that purpose-driven companies are more resilient in times of crisis. B Lab found that during the last recession, companies with a had a 63 percent better chance of surviving the downturn than other similar sized-companies.

“People — consumers, investors, everyone — are looking for inspiration and leadership now more than ever,” says Miyoko Schinner, an American chef, cookbook author, animal sanctuary founder and owner of dairy-free cheese Miyoko’s

The front facade of the New York Stock Exchange (NYSE) is seen in New York City, New York, U.S., June 26, 2020.

Brendan McDermid | Reuters

(This story is for CNBC Pro subscribers only). 

The market environment is pointing to a possible rally for stocks with stable dividends, Credit Suisse said in a note to clients.

The firm said that the number of stocks that qualify for its stable yield list has dropped significantly in recent years, but the ones that remain could be poised to outperform. 

“Historically, when treasury yields decline, investors demonstrate a preference for the bondlike profiles of Stable Yield stocks,” the note said.

Source link

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Info | Ad Choices 
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

Source link

Subscribe to The Capsule, a daily brief monitoring advances in health care and biopharma, delivered free to your inbox.

Adam Aron, CEO and president of AMC Theatres, the world’s largest chain of movie cinemas, remembers the early days of the pandemic as a blur. As the novel coronavirus spread around the world, he and his team scrambled to talk with health officials—first in Milan, then in Spain, then pretty much everywhere else the company operated, trying to sort out what to do with its 1,000 or so theaters in the middle of a fast-unfolding global health crisis.

The picture and the pace at which it was changing were dizzying. Over the course of a few days in mid-March, AMC announced plans to fill its theaters to only half capacity; then—prompted by an official’s remark on a Sunday morning talk show—AMC limited screenings to groups of 50 or fewer; and finally, on March 16, it closed its cinemas altogether.

“We had no experts on retainer internally,” says Aron, who admits when it came to understanding epidemiology and infection control and how to factor it into business, he and AMC’s senior execs were amateurs. “We were trying to make the best …